GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection

Laure Degroote; Jędrzej Chrzanowski; Pierre Lemaitre; Amber Wouters; Stephanie Bourgeois; Annelore Van Mulders; Julie Pierreux; Sophie Coenen; Lien Willems; Gunter Leuckx; Marijke Viaene; Marc Packbier; Jonathan D. Douros; Bin Yang; Yves Heremans; Chantal Mathieu; Willem Staels; Conny Gysemans; Nico De Leu

GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection

Laure Degroote
, Jędrzej Chrzanowski (Contributor)
, Pierre Lemaitre (Contributor)
, Amber Wouters (Contributor)
, Stephanie Bourgeois (Contributor)
, Annelore Van Mulders (Contributor)
, Julie Pierreux (Contributor)
, Sophie Coenen (Contributor)
, Lien Willems (Contributor)
, Gunter Leuckx (Contributor)
, Marijke Viaene (Contributor)
, Marc Packbier (Contributor)
, Jonathan D. Douros (Contributor)
, Bin Yang (Contributor)
, Yves Heremans (Contributor)
, Chantal Mathieu (Contributor)
, Willem Staels (Contributor)
, Conny Gysemans (Contributor)
, Nico De Leu (Contributor)

Onderzoeksoutput: Poster

Originele taal-2	English
Aantal pagina's	1
Status	Unpublished - 17 jun. 2026
Evenement	European Islet Study Group 2026 - Barcelona Biomedical Research Park (PRBB), Barcelona, Spain Duur: 17 jun. 2026 → 19 jun. 2026

Conference

Conference	European Islet Study Group 2026
Land/Regio	Spain
Stad	Barcelona
Periode	17/06/26 → 19/06/26

Toegang tot document

2026_Poster_EISG_Laure

Handle.net

Permanente koppeling

Citeer dit

Degroote, L., Chrzanowski, J., Lemaitre, P., Wouters, A., Bourgeois, S., Van Mulders, A., Pierreux, J., Coenen, S., Willems, L., Leuckx, G., Viaene, M., Packbier, M., Douros, J. D., Yang, B., Heremans, Y., Mathieu, C., Staels, W., Gysemans, C., & De Leu, N. (2026). GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection. Postersessie gepresenteerd op European Islet Study Group 2026, Barcelona, Spain.

@conference{6be47a5c640b45b29481f4f66f989fe2,

title = "GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection",

author = "Laure Degroote and J{\c e}drzej Chrzanowski and Pierre Lemaitre and Amber Wouters and Stephanie Bourgeois and \{Van Mulders\}, Annelore and Julie Pierreux and Sophie Coenen and Lien Willems and Gunter Leuckx and Marijke Viaene and Marc Packbier and Douros, \{Jonathan D.\} and Bin Yang and Yves Heremans and Chantal Mathieu and Willem Staels and Conny Gysemans and \{De Leu\}, Nico",

year = "2026",

month = jun,

day = "17",

language = "English",

note = "European Islet Study Group 2026 ; Conference date: 17-06-2026 Through 19-06-2026",

}

Degroote, L, Chrzanowski, J, Lemaitre, P, Wouters, A, Bourgeois, S , Van Mulders, A , Pierreux, J , Coenen, S , Willems, L , Leuckx, G, Viaene, M, Packbier, M, Douros, JD, Yang, B, Heremans, Y, Mathieu, C, Staels, W, Gysemans, C & De Leu, N 2026, 'GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection', European Islet Study Group 2026, Barcelona, Spain, 17/06/26 - 19/06/26.

TY - CONF

T1 - GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection

AU - Degroote, Laure

A2 - Chrzanowski, Jędrzej

A2 - Lemaitre, Pierre

A2 - Wouters, Amber

A2 - Bourgeois, Stephanie

A2 - Van Mulders, Annelore

A2 - Pierreux, Julie

A2 - Coenen, Sophie

A2 - Willems, Lien

A2 - Leuckx, Gunter

A2 - Viaene, Marijke

A2 - Packbier, Marc

A2 - Douros, Jonathan D.

A2 - Yang, Bin

A2 - Heremans, Yves

A2 - Mathieu, Chantal

A2 - Staels, Willem

A2 - Gysemans, Conny

A2 - De Leu, Nico

PY - 2026/6/17

Y1 - 2026/6/17

M3 - Poster

T2 - European Islet Study Group 2026

Y2 - 17 June 2026 through 19 June 2026

ER -